TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments
  • Shareholders Foundation monitors Class Action Investigations, Cases, and Class Action Settlements.
    Learn More >>>
  • Create Notifications and monitor one Case or multiple Cases. Or submit your entire portfolio! Learn More >>>

Omthera Pharmaceuticals Inc (NASDAQ:OMTH) Investor Files Lawsuit In Effort To Stop Takeover For $12.70 Per Share

  • Investors who purchased shares of Omthera Pharmaceuticals Inc (NASDAQ:OMTH) prior to May 28, 2013, and currently hold any of those NASDAQ:OMTH shares, you have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

June 18, 2013 (Shareholders Foundation) - An investor, who currently holds NASDAQ:OMTH shares, filed a lawsuit in effort to stop the takeover of Omthera Pharmaceuticals Inc by AstraZeneca, for $12.70 per NASDAQ:OMTH share. On 28 May 2013, AstraZeneca announced that it has entered into an agreement to acquire Omthera Pharmaceuticals Inc. Under the terms of the agreement, AstraZeneca ...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)